In updating our LASA system-wide policy, we have considered adding morphine oral liquid concentrate and morphine non-concentrated liquid. This pair is on ISMP's list of confused drug names. However, opioids are on our high alert medication policy. We were wondering if that's enough? Does your organization include this pair in your LASA policy? What strategies do you use to prevent a mix-up between these drugs in the ambulatory and acute care setting?